Abstract
The literature describes two treatment modalities for persistent lateral epicondylitis: surgical and conservative. While there are numerous conservative therapy options, there is no consensus in the literature regarding the optimal treatment. Although no treatment guide has been formed in the literature regarding prolotherapy injection, which is one of the conservative treatment modalities, each clinic has created its unique treatment protocol. Highly concentrated dextrose and morrhuate sodium solutions are most commonly used for prolotherapy. In this study, Visual Analogue Scale scores of 37 patients who were treated with double session 15% dextrose before the first injection and 6 months after the last injection were measured and compared statistically. It was also aimed to show possible complications. This study aimed to show the effectiveness of prolotherapy, one of the conservative treatment methods that seem to be ahead of other injection models in chronic lateral epicondylitis treatment because it is easily applicable, easily accessible, and affordable, and contributes to the literature by creating a treatment protocol.<p> </p><p><strong> Article visualizations:</strong></p><p><img src="/-counters-/edu_01/0971/a.php" alt="Hit counter" /></p>
Highlights
Prolotherapy is the injection of a hypertonic glucose solution into the injured tissue to stimulate inflammation, subsequent collagen deposition, and tendon remodeling
A statistically significant difference was found between pre-injection visual analog scale (VAS) and control VAS (p
A large number of injection therapies have been defined as a conservative treatment method for chronic lateral epicondylitis diagnosis in literature
Summary
There are a large number of non-surgical treatment options for CLE. These include pharmaceutical treatments (anti-inflammatory medication that can be used both systemical and local), forearm splints and braces, manual therapies (dorsiflexion exercises), extracorporeal shock wave therapy (ESWT), low-level laser therapy (LLLT), and trigger point injections (Bellapianta et al, 2011; Sims, Miller, Elfar, & Hammert, 2014). We will present our findings in this study about prolotherapy, a process that is less frequently utilized than other procedures but is more accessible and cost-effective. We will discuss our findings of prolotherapy, which is less frequently used than other procedures while being more accessible and cost-effective
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
